financetom
Business
financetom
/
Business
/
Root Insider Sold Shares Worth $373,302, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Root Insider Sold Shares Worth $373,302, According to a Recent SEC Filing
Jun 6, 2025 2:36 PM

05:07 PM EDT, 06/06/2025 (MT Newswires) -- Julie Szudarek, Director, on June 04, 2025, sold 2,790 shares in Root (ROOT) for $373,302. Following the Form 4 filing with the SEC, Szudarek has control over a total of 13,332 Class A common shares of the company, with 13,332 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1788882/000162828025030054/xslF345X05/wk-form4_1749243745.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chip lab imec names new CEO in AI-focused transition
Chip lab imec names new CEO in AI-focused transition
Sep 29, 2025
Sept 29 (Reuters) - Belgian chip research hub imec will appoint Patrick Vandenameele as its new chief executive with current CEO Luc Van den hove becoming chairman, the company told Reuters on Monday. Belgium's imec, one of the world's top semiconductor R&D firms, has made the change to help it adapt to the changing demands of artificial intelligence (AI) chipmaking,...
AstraZeneca Plans Direct Listing of Shares on NYSE
AstraZeneca Plans Direct Listing of Shares on NYSE
Sep 29, 2025
04:48 AM EDT, 09/29/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Monday it plans a direct listing of its shares on the New York Stock Exchange, replacing the existing US listing of its American depositary receipts on Nasdaq. The company's board recommended to its shareholders a harmonized listing structure for its shares across the London Stock Exchange, Nasdaq Stockholm...
GSK Names Luke Miels CEO Designate
GSK Names Luke Miels CEO Designate
Sep 29, 2025
04:49 AM EDT, 09/29/2025 (MT Newswires) -- GSK (GSK) said Monday it has appointed Luke Miels chief executive officer designate. Miels, who most recently served as the company's chief commercial officer, will assume the role and join the board on Jan. 1, succeeding Emma Walmsley. Walmsley is stepping down from GSK and is planning to pursue new ventures. Shares of...
Biogen, Eisai Say China Approves Maintenance Dosing Regimen for Alzheimer's Drug
Biogen, Eisai Say China Approves Maintenance Dosing Regimen for Alzheimer's Drug
Sep 29, 2025
04:53 AM EDT, 09/29/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Sunday their Alzheimer's therapy Leqembi has been approved for once every four weeks intravenous maintenance dosing by the National Medical Products Administration in China. Leqembi was earlier approved for the treatment of Alzheimer's disease in patients with mild cognitive impairment or mild dementia stage of disease in China,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved